176 related articles for article (PubMed ID: 25119188)
1. Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.
Park S; Park JA; Kim YE; Song S; Kwon HJ; Lee Y
Cell Stress Chaperones; 2015 Jan; 20(1):149-57. PubMed ID: 25119188
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cells.
Park S; Park JA; Yoo H; Park HB; Lee Y
Redox Biol; 2017 Oct; 13():470-476. PubMed ID: 28715732
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
Hui KF; Lam BH; Ho DN; Tsao SW; Chiang AK
Mol Cancer Ther; 2013 May; 12(5):747-58. PubMed ID: 23475956
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells.
Gillenwater AM; Zhong M; Lotan R
Mol Cancer Ther; 2007 Nov; 6(11):2967-75. PubMed ID: 18025281
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells.
Rosati R; Chen B; Patki M; McFall T; Ou S; Heath E; Ratnam M; Qin Z
Mol Pharmacol; 2016 Sep; 90(3):225-37. PubMed ID: 27382012
[TBL] [Abstract][Full Text] [Related]
6. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Li D; Marchenko ND; Moll UM
Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.
Chong W; Li Y; Liu B; Zhao T; Fukudome EY; Liu Z; Smith WM; Velmahos GC; deMoya MA; Alam HB
J Surg Res; 2012 Dec; 178(2):851-9. PubMed ID: 22868051
[TBL] [Abstract][Full Text] [Related]
8. HDAC inhibitor and proteasome inhibitor induce cleavage and exosome-mediated secretion of HSP90 in mouse pluripotent stem cells.
Choi JK; Park S; Park JA; Shin HE; Choi Y; Lee Y
Biochem Biophys Res Commun; 2022 Sep; 620():29-34. PubMed ID: 35777131
[TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels.
You BR; Park WH
Int J Oncol; 2014 May; 44(5):1745-55. PubMed ID: 24626405
[TBL] [Abstract][Full Text] [Related]
10. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species.
Ruefli AA; Ausserlechner MJ; Bernhard D; Sutton VR; Tainton KM; Kofler R; Smyth MJ; Johnstone RW
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10833-8. PubMed ID: 11535817
[TBL] [Abstract][Full Text] [Related]
11. Contribution of HSP90 Cleavage to the Cytotoxic Effect of Suberoylanilide Hydroxamic Acid
Park S; Kim D; Jung H; Choi IP; Kwon HJ; Lee Y
Biomol Ther (Seoul); 2024 Jan; 32(1):115-122. PubMed ID: 38148557
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells.
Li J; Liu R; Lei Y; Wang K; Lau QC; Xie N; Zhou S; Nie C; Chen L; Wei Y; Huang C
Autophagy; 2010 Aug; 6(6):711-24. PubMed ID: 20543569
[TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells.
Ruefli AA; Bernhard D; Tainton KM; Kofler R; Smyth MJ; Johnstone RW
Int J Cancer; 2002 May; 99(2):292-8. PubMed ID: 11979447
[TBL] [Abstract][Full Text] [Related]
14. Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
You BR; Park WH
Mol Carcinog; 2017 Dec; 56(12):2566-2577. PubMed ID: 28667779
[TBL] [Abstract][Full Text] [Related]
15. Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.
Chen H; Pan J; Wang JD; Liao QM; Xia XR
Inflammation; 2016 Feb; 39(1):39-46. PubMed ID: 26228975
[TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
Almenara J; Rosato R; Grant S
Leukemia; 2002 Jul; 16(7):1331-43. PubMed ID: 12094258
[TBL] [Abstract][Full Text] [Related]
17. Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
Bali P; Pranpat M; Swaby R; Fiskus W; Yamaguchi H; Balasis M; Rocha K; Wang HG; Richon V; Bhalla K
Clin Cancer Res; 2005 Sep; 11(17):6382-9. PubMed ID: 16144943
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.
Yu C; Rahmani M; Conrad D; Subler M; Dent P; Grant S
Blood; 2003 Nov; 102(10):3765-74. PubMed ID: 12893773
[TBL] [Abstract][Full Text] [Related]
19. The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2016 Feb; 51(2):274-82. PubMed ID: 26219406
[TBL] [Abstract][Full Text] [Related]
20. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
